- Home
- DENN vs NBTX Comparison
DENN vs NBTX Comparison
Compare DENN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DENN
- NBTX
- Stock Information
- Founded
- DENN 1953
- NBTX 2003
- Country
- DENN United States
- NBTX France
- Employees
- DENN N/A
- NBTX N/A
- Industry
- DENN Restaurants
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- DENN Consumer Discretionary
- NBTX Health Care
- Exchange
- DENN Nasdaq
- NBTX Nasdaq
- Market Cap
- DENN 203.4M
- NBTX 178.7M
- IPO Year
- DENN 1989
- NBTX 2020
- Fundamental
- Price
- DENN $4.47
- NBTX $3.41
- Analyst Decision
- DENN Strong Buy
- NBTX Strong Buy
- Analyst Count
- DENN 6
- NBTX 1
- Target Price
- DENN $7.46
- NBTX $8.00
- AVG Volume (30 Days)
- DENN 1.2M
- NBTX 7.6K
- Earning Date
- DENN 05-05-2025
- NBTX 04-02-2025
- Dividend Yield
- DENN N/A
- NBTX N/A
- EPS Growth
- DENN N/A
- NBTX N/A
- EPS
- DENN 0.33
- NBTX N/A
- Revenue
- DENN $453,997,000.00
- NBTX N/A
- Revenue This Year
- DENN $5.81
- NBTX N/A
- Revenue Next Year
- DENN $2.50
- NBTX $221.06
- P/E Ratio
- DENN $13.53
- NBTX N/A
- Revenue Growth
- DENN N/A
- NBTX N/A
- 52 Week Low
- DENN $2.85
- NBTX $2.76
- 52 Week High
- DENN $8.30
- NBTX $7.51
- Technical
- Relative Strength Index (RSI)
- DENN 70.88
- NBTX 52.75
- Support Level
- DENN $3.64
- NBTX $3.26
- Resistance Level
- DENN $4.60
- NBTX $3.65
- Average True Range (ATR)
- DENN 0.24
- NBTX 0.19
- MACD
- DENN 0.15
- NBTX 0.02
- Stochastic Oscillator
- DENN 90.91
- NBTX 35.00
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.